Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The local environment is crucial for cell development in the tongue.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.

Cedrol may be an effective treatment for colorectal cancer.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Male pattern baldness may increase COVID-19 severity risk.

m-Aminophenol in hair dye can cause skin cell toxicity and stress responses.

MK-386 reduces sebum DHT levels.

M-CSF-stimulated myeloid cells can turn into skin cells and help heal wounds and regrow hair.

Myeloid cells can turn into skin and hair cells to help heal wounds.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

A gene mutation in mice causes skin defects and early death.

Cystatin M/E helps in the final stages of hair and nail formation by controlling certain enzymes.

Lack of cystatin M/E causes thin hair and dry skin.

Albert M. Kligman made major contributions to dermatology, including inventing a stain for fungi and advancing knowledge on skin diseases, and his legacy continues through his trainees and philanthropy.

Albert M. Kligman, who turned 90 on March 17, 2006, made significant contributions to dermatology, including creating treatments for acne and studying skin aging.

Keratin 17 is important for skin's response to radiation, affecting many genes and cell division.